Finance

Lists
688278:SHA
Xiamen Amoytop Biotech Co Ltd
47,00 CN¥
-1,94%
(-0,93) 1D
16 қаз., 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688278...
Open
48,03 CN¥
High
48,99 CN¥
Low
46,56 CN¥
Mkt. cap
19,18 млрд
Avg. vol.
2,54 млн
Volume
2,77 млн
Dividend
1,32%
Quarterly dividend
0,15 CN¥
Ex-dividend date
2026 ж. 29 мам.
P/E ratio
17,87
52-wk high
85,57 CN¥
52-wk low
45,89 CN¥
EPS
2,63 CN¥
No. of employees
4 мың
Open
48,03 CN¥
High
48,99 CN¥
Low
46,56 CN¥
Mkt. cap
19,18 млрд
Avg. vol.
2,54 млн
Volume
2,77 млн
Dividend
1,32%
Quarterly dividend
0,15 CN¥
Ex-dividend date
2026 ж. 29 мам.
P/E ratio
17,87
52-wk high
85,57 CN¥
52-wk low
45,89 CN¥
EPS
2,63 CN¥
No. of employees
4 мың
News stories
From web sources and news partners
About Xiamen Amoytop Biotech Co Ltd
CEO-
Employees3,64 мың
Founded1996 ж. 07 там.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
968,93 млн
1,22 млрд
797,79 млн
1,04 млрд
Cost of goods sold
77,67 млн
75,46 млн
84,14 млн
119,01 млн
Cost of revenue
77,67 млн
75,46 млн
84,14 млн
119,01 млн
Research and development expenses
105,76 млн
108,69 млн
93,64 млн
103,15 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
507,38 млн
568,29 млн
420,50 млн
433,88 млн
Operating expense
601,16 млн
702,25 млн
517,13 млн
557,60 млн
Total operating expenses
678,83 млн
777,71 млн
601,27 млн
676,61 млн
Operating income
290,11 млн
438,31 млн
196,53 млн
362,16 млн
Other non operating income
-174,24 м.
-8,36 мың
-397,83 м.
253,31 м.
EBT including unusual items
254,73 млн
444,38 млн
179,04 млн
350,45 млн
EBT excluding unusual items
290,62 млн
441,89 млн
198,00 млн
361,73 млн
Income tax expense
16,50 млн
79,26 млн
14,55 млн
38,41 млн
Effective tax rate
6,48%
17,84%
8,12%
10,96%
Other operating expenses
-12,89 млн
25,22 млн
3,57 млн
19,67 млн
Net income
238,23 млн
365,11 млн
164,49 млн
312,03 млн
Net profit margin
24,59%
30,03%
20,62%
30,04%
Earnings per share
0,60
0,96
-
0,80
Interest and investment income
1,24 млн
4,63 млн
2,56 млн
1,93 млн
Interest expense
-384,44 м.
-660,14 м.
-686,79 м.
-1,76 млн
Net interest expenses
853,64 м.
3,97 млн
1,88 млн
173,29 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
306,99 млн
466,76 млн
224,97 млн
398,98 млн
Gain or loss from assets sale
21,30 мың
987,25 м.
-
-1,66 млн
AI content may include mistakes. Learn more
Google қолданбалары